Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review

INTRODUCTION: As oral factor Xa (oFXa) inhibitor use has increased, so has publication of case series describing related bleeding managed with four-factor prothrombin complex concentrate (4F-PCC). OBJECTIVE: This review aimed to identify case series describing 4F-PCC management of oFXa inhibitor-rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Olivia S, Baker, William L, Roman-Morillo, Yuani, McNeil-Posey, Kelly, Lovelace, Belinda, White, C Michael, Coleman, Craig I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646359/
https://www.ncbi.nlm.nih.gov/pubmed/33154059
http://dx.doi.org/10.1136/bmjopen-2020-040499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646359/
https://www.ncbi.nlm.nih.gov/pubmed/33154059
http://dx.doi.org/10.1136/bmjopen-2020-040499

Ejemplares similares